A股異動 | 貝因美(002570.SZ)盤中漲停 月內走出V型反轉行情 創6個月新高
格隆匯2月14日丨貝因美(002570.SZ)盤中一度直線拉昇封漲停,月內累計漲15%走出V型反轉行情,現報5.84元創6個月新高價,成交額放大至6.06億元,總市值63億元。日前貝因美預計2021年淨利潤同比增長118.5%-127.75%,扣除非經常性損益後的淨利潤也為正數,成功實現扭虧為盈。業內人士分析,對於貝因美而言,2021年業績預盈,結束了公司淨利潤連續兩年虧損、扣非淨利潤連續5年虧損的歷史,在經營業績上走上正軌。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.